Print   



NextGen Group plc ('NextGen' or the 'Company')

Fundraising of £750,000 by way of Placing

NextGen is pleased to announce that it has raised £750,000 by way of a placing of new ordinary shares of 0.1 pence each (the 'Placing Shares'). This funding will provide general working capital for the Company, which the Directors believe will be sufficient for its current requirements. 

The Company has placed 750,000,000 ordinary shares of 0.1 pence each (the 'Placing Shares') with an existing shareholder in the Company (the 'Placing'). The Placing Shares are to be issued at 0.1 pence per share to raise £750,000 before expenses. 

In addition, for every Placing Share issued pursuant to the Placing, the Company will grant a warrant over 1 ordinary share of 0.1 pence each (the 'Ordinary Shares') with an exercise price of 0.1 pence per share. Accordingly, warrants over 750,000,000 Ordinary Shares will be granted pursuant to the Placing. The Warrants shall be exercisable for 3 years from the date of grant.

Following the Placing, the Company will have in issue 3,796,978,644 Ordinary Shares. The Placing Shares will represent 19.75 per cent of the enlarged issued share capital immediately following the issue of the Placing Shares and will rank pari passu in all respects with the existing Ordinary Shares.

The Placing Shares are being subscribed for by Family Trust Select - FIS - Teilfonds Zeus, a Luxembourg fund managed Family Trust Management S.a.r.l. (the 'Family Trust Select'). On completion of the Placing, Family Trust Select will hold 66.48 per cent. of the then issued share capital of the Company and if Family Trust Select was to immediately exercise all of the warrants it holds after the Placing, it would hold 76.64 per cent. of the then issued share capital of the Company. 

As the Company is not centrally managed and controlled in the UK, Channel Islands or Isle of Man, it is not subject to the City Code on Takeovers and Mergers ('City Code'). Accordingly the Placing is not subject to the City Code. Investors should be aware that they are not afforded the protections of the City Code.

Application will be made for the Placing Shares to be admitted to trading on the AIM market of the London Stock Exchange and admission of the shares is expected to be on 15 August 2009. The warrants will not be admitted to trading on AIM. The Placing Shares and any new Ordinary Shares to be issued upon exercise of the warrants will rank pari passu with the existing Ordinary Shares of the Company. 

For further details please contact:

NextGen Group 

Klaus Rosenau, Chairman

+49 160 5516756

Jonathan Wright/Nicola Marrin

Seymour Pierce Limited                         020 7107 8000

Notes to Editors:

About NextGen Sciences

NextGen Group PLC (LSE:NGG) is a provider of expert systems, services and reagents focused on enabling enhanced access to and understanding of the role of proteins in diagnosis and drug discovery. The expert systems are built out of NextGen's understanding of biological sciences and combine robotics, advanced engineering and rules based software in systems that range from partial to fully automated. NextGen also uses its systems and instruments to provide fee-for-service products under the Brand Name contractexpressTM to the pharmaceutical and biotechnology industry as well as those in academic research. 

NextGen Group PLC floated on the AIM market in London in December 2005 raising £2.4 million in an oversubscribed offering which included strong institutional investor support from Germany as well as in the UK. Further details relating to NextGen Group PLC and its products can be found at www.nextgensciences.com

---

ENDIOECKDKBABKDQFD